Flavonoid resveratrol modulates transcription factor NF-κB, cytochrome P450 isoenzyme CYP1A1, expression and activity of cyclooxygenase (COX) enzymes, Fas/Fas ligand mediated apoptosis, p53, mTOR and cyclins and various phosphodiesterases, which increases cytosolic cAMP that activates Epac1/CaMKKβ/AMPK/SIRT1/PGC-1α pathway that, in turn, facilitates increased oxidation of fatty acids, mitochondrial biogenesis, mitochondrial respiration, and gluconeogenesis. Resveratrol triggers apoptosis of activated T cells and suppresses tumor necrosis factor-α (TNF-α), interluekin-17 (IL-17) and other pro-inflammatory molecules and thus, is of benefit in autoimmune diseases. In addition, resveratrol inhibits expressions of (hypoxia inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) explaining its effective action against cancer.
Introduction
The hypothesis that certain flavonoids such as resveratrol protect against dementia seen in elderly diabetic patients is interesting. The epidemic of obesity and type 2 diabetes mellitus that is sweeping both the developed and developing countries could be one reason for the increasing incidence of senile dementia. Consumption of high fat/high calorie diet, refined carbohydrates, and trans-fats and lack of adequate exercise is considered to be responsible for this epidemic of obesity and metabolic syndrome and consequent increase in the risk of coronary and cerebrovascular diseases, certain types of cancers, hypertension, and non-alcoholic fatty liver disease (NAFLD) and Alzheimer's disease (1) (2) (3) . It has been suggested that an increase in the consumption of dietary fibre, flavonoids, anti-oxidant micronutrients and ω-3 polyunsaturated fatty acids (PUFAs) is beneficial. An imbalance in the modern dietary habit(s) as outlined above can lead to an increase in oxidative stress and endoplasmic reticulum (ER) stress that initiates the development of insulin resistance and onset of type 2 diabetes mellitus and Alzheimer's disease. Yorimitsu et al (4) showed that endomembranes progressively store misfolded proteins which causes ER stress, since unfolded proteins could trigger expression of chaperones resulting in autophagic cell death, included those of neuronal cells (5) . Autophagic activity dysregulation is related to obesity and type 2 diabetes mellitus (6) . ER stress and low-grade systemic inflammation seen in M A N U S C R I P T
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Page 3 of 14 obesity leads to impairment of insulin sensitivity pathway, peripheral insulin resistance and subsequent development of type 2 diabetes mellitus. This is supported by the work of Yin et al (7) , who showed that adipocytes pre-loaded with the saturated fatty acid palmitate leads to endoplasmic reticulum stress and autophagy via protein kinase C-mediated signaling pathway independent of mammalian target of rapamycin (mTOR) (8) .
Resveratrol has anti-oxidant actions and increases oxidation of fatty acids, mitochondrial biogenesis, mitochondrial respiration, and gluconeogenesis
One of the best ways to stem the epidemic of obesity, type 2 diabetes mellitus and Alzheimer's disease is to restrict calorie intake and do regular exercise that would lead to a decrease in endoplasmic reticulum stress. In this context, it is interesting to note that some of the beneficial actions of resveratrol seem to mimic several of the biochemical effects of calorie restriction. Resveratrol activates Sirtuin 1 (SIRT1) (9) and peroxisome proliferator-activated receptor-γ coactivator1α (PGC-1α) and improves the functioning of the mitochondria (10, 11) . Recent studies have revealed that resveratrol binds to tyrosyl transfer-RNA (tRNA) synthetase (TyrRS) to potentiate a poly(ADP-ribose) polymerase 1) (PARP1)/NAD+ driven signaling cascade to activate p53 and AMPK by inhibiting SIRT1 (12) . Cells treated with resveratrol showed a fourteen-fold increase in the action of superoxide dismutase (SOD) that removes superoxide anion, a potent free radical (13) . SOD by reducing superoxide restores mitochondrial dysfunction to normal. Resveratrol by activating SIRT1 causes migration of FOXO transcription factors to the nucleus (14) , which stimulates FOXO3a transcriptional activity (15) and was shown to enhance the sirtuincatalyzed deacetylation (activity) of FOXO3a. SOD is a target of FOXO3a, and MnSOD expression is strongly induced in cells overexpressing FOXO3a (16) . It is known that high expression of SOD but mild changes in catalse (CAT) and glutathione peroxidase (GPX) expression in cancer cells results in the mitochondrial accumulation of H2O2, which in turn induces cancer cell apoptosis (17) . It appears that both exercise and resveratrol induce disproportional up-regulation of SOD, CAT and GPX to bring about their beneficial actions in cancer.
In addition, resveratrol modulates the transcription factor NF-κB, inhibits the cytochrome P450 isoenzyme CYP1A1 and suppresses the expression and activity of cyclooxygenase (COX) enzymes, and modulates Fas/Fas ligand mediated apoptosis, p53, mTOR and cyclins A, B1, and cyclin-dependent kinases cdk 1 and 2 that may also account for its benefits (18) (19) (20) (21) . These actions of resveratrol (9-21) may be responsible for its benefit M A N U S C R I P T
Page 4 of 14 in Alzheimer's disease (22) . Resveratrol competitively inhibits various phosphodiesterases and thus, increases cytosolic cAMP, which acts as a second messenger for the activation of the pathway Epac1/CaMKKβ/AMPK/SIRT1/PGC-1α that facilitates an increase in oxidation of fatty acids, mitochondrial biogenesis, mitochondrial respiration, and gluconeogenesis (23, 24, see Figure 1 ).
Resveratrol has anti-inflammatory actions
On exposure to different immune stimuli, naïve T cells are activated, undergo proliferation and are made to undergo differentiation into three distinct functional subsets: expressions of HIF-1α and VEGF implying that it could be an effective anticancer therapy for the prevention of cancer and metastasis (36-38).
Resveratrol is cytoprotective in nature
Increasing incidence of obesity and metabolic syndrome all over the world has been attributed not only to high-fat diet and lack of exercise but also to certain environmental factors such bisphenol-A (BPA), an endocrine disruptor present in plastic. A cross-sectional study performed in 76 out of 139 environmentally exposed adult males, unselected Caucasian subjects, enrolled by routine health survey at the "Federico II" University of Naples outpatient facilities, revealed that BPA and pro-inflammatory cytokine levels were significantly higher in subjects with visceral adiposity. BPA correlated with visceral obesity, triglycerides, glucose homeostasis and inflammatory markers. At the multivariate analysis WC and IL-6 remained the main predictors of BPA. These results supports that BPA and other environmental factors may play a role in visceral obesity-related low grade chronic inflammation (39) . Similar association between BSA and autism has also been described (40) . (resveratrol) may have the ability to augment BDNF synthesis and action since BDNF also has similar beneficial actions in these diseases (42, 46) . In a recent study, we noted that BDNF levels are low in subjects with type 2 diabetes mellitus (47) and that it interacts and enhances the production of an anti-inflammatory bioactive lipid namely, lipoxin A4, whose levels are also low in diabetes mellitus (47) (48) (49) . Lipoxin A4 is a potent suppressor of proinflammatory prostaglandin E2 synthesis (50) . This rises the interesting possibility that resveratrol may augment the production of lipoxin A4 and block that of prostaglandin E2
and thus, is able to bring about its beneficial actions in several diseases including autism, obesity, diabetes mellitus, metabolic syndrome, depression, schizophrenia and cancer (22, 24,
43-51).
There are two other potential mechanims by which resveratrol acts: (i) by altering gut microbiota that have a role in several diseases and (ii) influencing stem cell proliferation and differentiation (52) (53) (54) (55) .
Conclusions
Despite many beneficial actions of resveratrol, one major concern is its poor solubility and absorption when given orally. Poor bioavailability of resveratrol is attributed to its extensive hepatic gluconuridation and sulfation. A recent study (56) 
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• We review the action of resveratrol on multiple enzymes, transcription factors and metabolic pathways.
• Resveratrol effects include facilitation of increased oxidation of fatty acids, mitochondrial biogenesis, mitochondrial respiration, and gluconeogenesis.
• Resveratrol inhibits expressions of HIF-1α and VEGF explaining its effective action against cancer.
• Resveratrol triggers apoptosis of activated T cells and suppresses pro-inflammatory molecules and thus, is of benefit in autoimmune diseases.
• Resveratrol alters gut microbiota and influences stem cell proliferation and differentiation.
